TKNO Alpha Teknova, Inc.
Stock · NasdaqGM · United States · Healthcare · US02080L1026
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by Alpha Teknova, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD.
Updated 08 Nov 2026 14:53. Information, not advice.
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 25 Feb 2027 16:00 | -0.08 | — | — | Upcoming |
| 04 Nov 2026 16:00 | -0.05 | -0.06 | -20.0% | Miss |
| 05 Aug 2026 16:00 | -0.07 | -0.05 | +32.1% | Beat |
| 06 May 2026 16:00 | -0.09 | -0.08 | +13.0% | Beat |
| 26 Feb 2026 16:00 | -0.09 | -0.09 | +2.2% | Beat |
| 06 Nov 2025 16:00 | -0.09 | -0.08 | +14.9% | Beat |
| 07 Aug 2025 16:00 | -0.10 | -0.07 | +30.0% | Beat |
| 08 May 2025 16:00 | -0.11 | -0.09 | +16.3% | Beat |
| 04 Mar 2025 16:00 | -0.12 | -0.11 | +8.3% | Beat |
| 07 Nov 2024 16:00 | -0.11 | -0.15 | -33.3% | Miss |
| 13 Aug 2024 16:00 | -0.16 | -0.13 | +20.4% | Beat |
| 13 May 2024 16:00 | -0.25 | -0.20 | +18.9% | Beat |
| 11 Mar 2024 16:00 | -0.20 | -0.20 | -1.3% | Miss |
| 09 Nov 2023 16:00 | -0.27 | -0.26 | +2.3% | Beat |
| 10 Aug 2023 16:00 | -0.28 | -0.18 | +37.4% | Beat |
| 11 May 2023 16:00 | -0.28 | -0.31 | -10.7% | Miss |
| 15 Mar 2023 16:00 | -0.34 | -0.47 | -36.2% | Miss |
| 09 Nov 2022 16:00 | -0.29 | -0.22 | +26.1% | Beat |
| 10 Aug 2022 16:00 | -0.25 | -0.22 | +12.0% | Beat |
| 12 May 2022 16:00 | -0.21 | -0.20 | +7.0% | Beat |
| 15 Mar 2022 16:00 | -0.15 | -0.13 | +13.3% | Beat |
| 12 Nov 2021 06:00 | -0.12 | -0.10 | +16.4% | Beat |
| 11 Aug 2021 16:00 | -0.18 | -0.45 | -150.1% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 40.5M | +7.4% | -17.3M | -42.6% | -0.32 | +43.9% | -9.8M |
| 2024 | 37.7M | +2.9% | -26.7M | -70.9% | -0.57 | +50.9% | -13.5M |
| 2023 | 36.7M | -11.4% | -36.8M | -100.3% | -1.16 | +31.4% | -26.7M |
| 2022 | 41.4M | — | -47.5M | -114.6% | -1.69 | — | -55.5M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 23 Jan 2025 | 8.33 | 8.76 | 8.15 | 8.76 | +4.91% | 206,300 | |
| 22 Jan 2025 | 8.35 | 8.50 | 8.02 | 8.35 | +2.45% | 214,700 | |
| 21 Jan 2025 | 7.99 | 8.31 | 7.89 | 8.15 | +0.99% | 96,700 | |
| 17 Jan 2025 | 7.58 | 8.10 | 7.58 | 8.07 | +7.17% | 130,400 | |
| 16 Jan 2025 | 7.87 | 7.89 | 7.15 | 7.53 | -4.92% | 463,500 | |
| 15 Jan 2025 | 8.15 | 8.53 | 7.77 | 7.92 | +0.13% | 240,800 | |
| 14 Jan 2025 | 8.10 | 8.42 | 7.66 | 7.91 | -2.10% | 225,700 | |
| 13 Jan 2025 | 7.88 | 8.29 | 7.80 | 8.08 | +0.25% | 153,000 | |
| 10 Jan 2025 | 7.80 | 8.45 | 7.74 | 8.06 | -4.05% | 245,100 | |
| 08 Jan 2025 | 8.90 | 8.93 | 8.40 | 8.40 | -6.77% | 270,200 | |
| 07 Jan 2025 | 9.15 | 9.43 | 8.48 | 9.01 | -0.55% | 179,200 | |
| 06 Jan 2025 | 8.71 | 9.31 | 8.63 | 9.06 | +4.02% | 240,200 | |
| 03 Jan 2025 | 8.50 | 8.96 | 8.28 | 8.71 | +4.69% | 104,400 | |
| 02 Jan 2025 | 8.24 | 8.76 | 7.89 | 8.32 | -0.36% | 186,000 | |
| 31 Dec 2024 | 9.00 | 9.05 | 8.17 | 8.35 | -5.65% | 1,488,000 | |
| 30 Dec 2024 | 8.51 | 9.05 | 8.40 | 8.85 | +1.37% | 271,100 | |
| 27 Dec 2024 | 8.87 | 9.57 | 8.33 | 8.73 | -2.68% | 266,300 | |
| 26 Dec 2024 | 8.49 | 9.22 | 8.34 | 8.97 | +4.30% | 327,600 | |
| 24 Dec 2024 | 7.97 | 9.72 | 7.79 | 8.60 | +11.98% | 635,700 | |
| 23 Dec 2024 | 7.73 | 7.73 | 7.43 | 7.68 | -0.65% | 106,500 | |
| 20 Dec 2024 | 7.28 | 8.08 | 7.28 | 7.73 | +6.77% | 322,300 | |
| 19 Dec 2024 | 7.93 | 8.18 | 7.00 | 7.24 | -9.16% | 451,300 | |
| 18 Dec 2024 | 8.69 | 8.69 | 7.97 | 7.97 | -7.43% | 184,200 | |
| 17 Dec 2024 | 8.73 | 8.84 | 8.40 | 8.61 | -2.27% | 114,600 | |
| 16 Dec 2024 | 8.23 | 8.89 | 8.11 | 8.81 | +9.71% | 173,600 |
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Alpha Teknova Inc (TKNO) (Q3 2026) Earnings Call Highlights: Record Revenue, Surging Clinical ... (opens in a new tab) GuruFocus.com · 05 Nov 2026 19:08
- Alpha Teknova (TKNO) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 05 Nov 2026 16:13
- Alpha Teknova Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 05 Nov 2026 08:14
- Alpha Teknova (TKNO) Reports Q3 Loss, Tops Revenue Estimates (opens in a new tab) Zacks · 04 Nov 2026 23:45
- Alpha Teknova, Inc. (TKNO) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 04 Nov 2026 22:24
- Alpha Teknova: Q3 Earnings Snapshot (opens in a new tab) Associated Press · 04 Nov 2026 21:46
- Alpha Teknova Q3 2026 Earnings Call Transcript (opens in a new tab) Benzinga · 04 Nov 2026 20:06
- Alpha Teknova Raises FY2026 Sales Guidance from $45.000M-$47.000M to $46.000M-$48.000M vs $46.058M Est (opens in a new tab) Benzinga · 04 Nov 2026 17:01
- Alpha Teknova Q3 EPS $(0.06) Beats $(0.07) Estimate, Sales $12.704M Beat $11.639M Estimate (opens in a new tab) Benzinga · 04 Nov 2026 17:01
- Full-Year Revenue Guidance Hike Drove Alpha Teknova (TKNO) Higher (opens in a new tab) Insider Monkey · 30 Oct 2026 14:23
- Alpha Teknova (TKNO) Stock Jumps 5.1%: Will It Continue to Soar? (opens in a new tab) Zacks · 23 Oct 2026 12:38
- Alpha Teknova stock tumbles on public offering announcement (opens in a new tab) Investing.com · 20 Oct 2026 22:47
- All You Need to Know About Alpha Teknova (TKNO) Rating Upgrade to Buy (opens in a new tab) Zacks · 01 Oct 2026 16:00
- Alpha Teknova (TKNO) Moves 7.1% Higher: Will This Strength Last? (opens in a new tab) Zacks · 22 Sep 2026 13:53
- Alpha Teknova Raises Outlook After Record Q2 Revenue at Sidoti Conference (opens in a new tab) MarketBeat · 20 Aug 2026 03:02
Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 7.88 USD
- Market cap
- 491.3M
- Exchange
- NasdaqGM
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- USD
Dividends
No dividends on record.
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 0.0 / 25 |
|
| Quality Return on equity, net margin and how stable the margins are. | 0.0 / 25 |
|
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 5.0 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 2.5 / 15 |
|
| Analysts How far the analysts' average target is from today's price. | 10.0 / 10 |
|
- Score capped at 60: free cash flow was negative in two of the last three years
- Thin interest cover: operating profit is only -23.9× the interest
- The last full year was a loss
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A). Warnings take 12 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (forward) | -41.11× | Weak | 14.94× |
| Price / book | 7.02× | Weak | 3.81× |
| Price / sales | 10.69× | Weak | 3.19× |
| EV / EBITDA | -52.64× | Weak | 12.63× |
| Free cash flow yield | 0% | Weak | 2.6% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 36.4% | Fair | 58.6% |
| Operating margin | -25.2% | Weak | 7.8% |
| Net margin | -34.8% | Weak | 2.8% |
| Return on equity | -24.1% | Weak | 5.7% |
| Return on assets | -9% | Weak | 3.6% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | -0.7% | Weak | 10.8% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0.45× | Good | 0.48× |
| Interest cover | -23.91× | Weak | 2.76× |
| Current ratio | 3.56× | Good | 2.35× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 0% | Weak | 0% |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Follow TKNO and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.